β-glucocerebrosidase gene locus as a link for Gaucher's disease and familial hypo-α-lipoproteinaemia

被引:36
|
作者
Pocovi, M
Cenarro, A
Civeira, F
Torralba, MA
Perez-Calvo, JI
Mozas, P
Giraldo, P
Giralt, M
Myers, RH
Cupples, LA
Ordovas, JM
机构
[1] Univ Zaragoza, Fac Sci, Dept Biochem Mol & Cellular Biol, E-50009 Zaragoza, Spain
[2] Univ Hosp, Dept Internal Med, Zaragoza, Spain
[3] Hosp Miguel Servet, Dept Internal Med, Zaragoza, Spain
[4] Hosp Miguel Servet, Dept Haematol, Zaragoza, Spain
[5] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA
[6] Boston Univ, Sch Med, Dept Publ Hlth, Boston, MA 02118 USA
[7] Tufts Univ, Lipid Metab Lab JM HNRCA, Boston, MA 02111 USA
来源
LANCET | 1998年 / 351卷 / 9120期
关键词
D O I
10.1016/S0140-6736(97)09490-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Gaucher's disease is the most common lysosomal storage disorder, caused by deficiency of glucocerebrosidase resulting from homozygosity for any of several mutations of the glucocerebrosidase gene locus. Affected people have decreased concentrations of LDL cholesterol (LDL-C) and HDL cholesterol (HDL-C). We assessed the association between mutations in the glucocerebrosidase locus and hypo-alpha-lipoproteinaemia. Methods We studied 258 people from 43 unrelated Spanish families. 57 participants were affected, 137 were nonaffected carriers, and 64 were non-carriers. We determined glucocerebrosidase genotypes and measured plasmid lipids, apolipoproteins A-I, B, and E, and leucocyte glucocerebrosidase activity. Findings The most common glucocerebrosidase mutations were N37OS (45%), L444P (23%), and G377S (5%). Deletions and recombinants accounted for another 5%, and point mutations in exons 5, 6, 9, and 10 were present in 12%, Affected participants had lower LDL-C and HDL-C concentrations than non-affected carriers (p<0.001) and non-carriers (p<0 001). HDL-C values were also significantly different between the non-affected carriers and non-carriers. Mutations at this locus may account for as much as 19.5% of the genetic variability in HDL-C in the population studied. Interpretation Heterozygosity for these mutations at the glucocerebrosidase locus does not result in clinical expression of Gaucher's disease but can decrease HDLC concentrations, Given the high frequency of these mutations, the glucocerebrosidase locus might lead to familial low alpha-lipoproteinaemia in up to 2% of the general population and be one of the most common known genetic causes of HDL-C.
引用
收藏
页码:1919 / 1923
页数:5
相关论文
共 50 条
  • [31] GENE-MAPPING AND LEADER POLYPEPTIDE SEQUENCE OF HUMAN GLUCOCEREBROSIDASE - IMPLICATIONS FOR GAUCHER DISEASE
    GINNS, EI
    CHOUDARY, PV
    TSUJI, S
    MARTIN, B
    STUBBLEFIELD, B
    SAWYER, J
    HOZIER, J
    BARRANGER, JA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (20) : 7101 - 7105
  • [32] Different sites of recombination between the glucocerebrosidase gene and pseudogene in patients with Gaucher disease.
    Tayebi, N
    Stubblefield, BK
    DamschroderWilliams, P
    Cushner, S
    Lau, E
    Sidransky, E
    PEDIATRIC RESEARCH, 1996, 39 (04) : 875 - 875
  • [33] RECTL - A COMPLEX ALLELE OF THE GLUCOCEREBROSIDASE GENE ASSOCIATED WITH A MILD CLINICAL COURSE OF GAUCHER DISEASE
    ZIMRAN, A
    HOROWITZ, M
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1994, 50 (01): : 74 - 78
  • [34] Identification of novel mutations in glucocerebrosidase (GBA) gene in Indian patients with gaucher disease (GD)
    Chitra Ankleshwaria
    Jayesh Sheth
    Mehul Mistri
    Ashish Bavdekar
    Sheela Nampoothiri
    Sarita Gupta
    Frenny Sheth
    Molecular Cytogenetics, 7 (Suppl 1)
  • [35] Glucocerebrosidase (GBA) mutations and familial Parkinson's disease in Japan
    Sekine, T.
    Li, L.
    Li, Y.
    Imamichi, Y.
    Yoshino, H.
    Funayama, M.
    Tomiyama, H.
    Kubo, S.
    Hattori, N.
    MOVEMENT DISORDERS, 2009, 24 : S152 - S152
  • [36] GLUCOCEREBROSIDASE GENE MUTATION IN PARKINSON'S DISEASE
    Macas, M.
    Ng, E. Y.
    Parimelalagan, M.
    Tan, E. K.
    PARKINSONISM & RELATED DISORDERS, 2018, 46 : E15 - E15
  • [37] Genotype/phenotype relationship in Gaucher disease patients. Novel mutation in glucocerebrosidase gene
    Lepe-Balsalobre, Esperanza
    Santotoribio, Jose D.
    Nunez-Vazquez, Ramiro
    Garcia-Morillo, Salvador
    Jimenez-Arriscado, Pilar
    Hernandez-Arevalo, Paula
    Delarosa-Rodriguez, Rocio
    Guerrero, Juan M.
    Macher, Hada C.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (12) : 2017 - 2024
  • [38] A GLUCOCEREBROSIDASE FUSION GENE IN GAUCHER DISEASE - IMPLICATIONS FOR THE MOLECULAR ANATOMY, PATHOGENESIS, AND DIAGNOSIS OF THIS DISORDER
    ZIMRAN, A
    SORGE, J
    GROSS, E
    KUBITZ, M
    WEST, C
    BEUTLER, E
    JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (01): : 219 - 222
  • [39] Analysis of the glucocerebrosidase gene in Parkinson's disease
    Sato, C
    Morgan, A
    Lang, AE
    Salehi-Rad, S
    Kawarai, T
    Meng, Y
    Ray, PN
    Farrer, LA
    St George-Hyslop, P
    Rogaeva, E
    MOVEMENT DISORDERS, 2005, 20 (03) : 367 - 370
  • [40] Mutations in the Glucocerebrosidase gene and Parkinson's disease
    Clark, LN
    Wang, YJ
    Fahn, S
    Ottman, R
    Marder, K
    NEUROLOGY, 2006, 66 (05) : A143 - A143